Philadelphia Business Journal - by John George , Staff Writer
Date: Wednesday, January 19, 2011, 4:36pm EST.
The University City Science Center said Wednesday it has awarded three $200,000 grants to area researchers studying cancer, hepatitis C, and microRNA molecules through its QED proof-of-concept program.
The research and development funding includes $100,000 from the Science Center and a $100,000 match from each of three supporting institutions: The Children’s Hospital of Philadelphia, Temple University and the University of Pennsylvania.
In addition to the financial award, each of the three principal investigators will receive one year of continued business guidance to help them bring their technologies to market.
The grant recipients were:
• Linda B. Couto, associate director in the Center for Cellular and Molecular Therapeutics at Children's Hospital of Philadelphia, who is working on a novel treatment for people infected with hepatitis C virus that uses microRNA technology to overcome the problem of drug resistance;
• George P. Tuszynski, a professor of Neuroscience at Temple University’s School of Medicine, who is working on a protein-based therapy for acute myeloid leukemia that shows promise in reverting cultured leukemic cells to normal cells; and
• Marija Drndic, an associate professor at the University of Pennsylvania, who is leading a group of Penn researchers developing a “lab-on-a-chip tool” for measuring microRNA molecules, which regulate gene activity in normal and disease states.
The Science Center reviewed 45 applications for its third round of QED program grants before selecting the three recipients.
Source
No comments:
Post a Comment